Lamivudine for the Treatment of Membranous Glomerulopathy Secondary to Chronic Hepatitis B Infection
Membranous glomerulopathy is a well-recognized extrahepatic manifestation of chronic hepatitis B virus (HBV) infection. The authors report two cases of HBV-related nephrotic syndrome treated with lamivudine. A 46-year-old Chinese man had a hepatitis B e antigen seroconversion along with improvement...
Main Authors: | SI Gan, SM Devlin, NW Scott-Douglas, KW Burak |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2005-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2005/378587 |
Similar Items
-
Complete Remission of Nephrotic Syndrome of Hepatitis B Virus-associated Membranous Glomerulopathy After Lamivudine Monotherapy
by: Tang-Wei Chuang, et al.
Published: (2007-10-01) -
Lamivudine for chronic hepatitis B: a brief review
by: Emilio Palumbo -
Successful lamivudine therapy for chronic hepatitis B in the family
by: Nožić Darko
Published: (2006-01-01) -
Treatment of chronic hepatitis B in Oman experience with lamivudine
by: Upadhyay Dip Amal, et al.
Published: (2003-01-01) -
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01)